baber/WOPTO huggingface dataset:
Patent CA-3014361-A1 (CA)
Inventor: CHRAPKO EVAN V
IPC: G06Q30/00
Filed: 2017-03-20
Abstract: Systems and methods are described herein for learning an entity's trust model and risk tolerance. An entity's trust score may be calculated based on data from a variety of data sources, and this data may be combined according to a set of weights which reflect an entity's trust model and risk tolerance. An entity may weight data of a certain type more heavily for certain types of transactions and another type of data more heavily for other transactions. A  system may predict the entity's trust model and risk tolerance and adjust the set of weights accordingly for calculating trust scores. By monitoring how entities adjust weights for different transaction types, default weighting profiles may be customized for specific transaction types. An entity's trust score, as reported to a requesting entity, may be adjusted based on that requesting entity's own trust model.
Patent CA-3020628-A1 (CA)
Title: Depistage d'une dysplasie pancreatique de haut grade
Inventor: AHLQUIST DAVID A
IPC: C12N15/11
Filed: 2017-04-13
Abstract: L'invention concerne une technologie de criblage permettant d'identifier une dysplasie pancréatique de haut grade et, en particulier, mais non exclusivement, des méthodes, des compositions, et des utilisations associées pour dépister la présence d'une dysplasie pancréatique de haut grade (IPMN-HGD, PanIN-3, ou PDAC).
Patent CA-3021940-A1 (CA)
Inventor: ZHENG KELI
IPC: G02C7/08
Filed: 2018-10-24
Abstract: The present invention discloses a holographic eyeglass lens. The holographic eyeglass lens comprises a lens body whose central attention optical zone is a free-focus lens, and is provided with a butterfly-shaped holographic zoom ring in a direction from an optical center to the edge of the lens, wherein the radius of the butterfly-shaped holographic zoom ring is not smaller than 4.5 mm. An optical path guide zone is arranged at the periphery of the lens. The free-focus lens serves to freely focus within a range of 16 mm from the optical center. A zone of moving 4.5 mm from the optical center towards the outer edge of the lens is defined as a high-beam focus zone. A zone of moving from 4.5 mm to 11.5 mm is defined as a mid-beam focus zone. Then, a zone of moving from 11.5 mm to 16 mm is defined as a low-beam focus zone. A zone from 16 mm to 38 mm, i.e., the outermost edge of the lens, is defined as the optical path guide zone. The holographic eyeglass lens of the present invention brings distinct images and rich gradation in visual sense and has good effects of filtering ultraviolet rays, and other light waves of stray light and glare light harmful to sights of the eyes.
Patent CA-3026153-A1 (CA)
Inventor: LINNEMANN LARS
IPC: B29B17/04
Filed: 2017-06-01
Abstract: The invention relates to a method for manufacturing a pellet, comprising a) providing residual rubber powder from a rubber disintegration process; b) providing a pelletizing system, including a pelletizer and a cooling device; c) feeding the residual rubber powder as at least part of a feed material, into a pelletizer; d) providing the rubber powder in an amount between 50% and 100%;  e) applying a pressure to the residual rubber for a predetermined process duration; f) releasing the pelletized rubber and cooling the pelletized rubber at a cooling rate dependent on the operational temperature of the pelletizer.
Patent CA-3027557-A1 (CA)
Title: Pansement medical
Inventor: OSTAN KARIN
IPC: A61F13/00
Filed: 2017-06-14
Abstract: Cette invention présente un pansement médical. Il comprend un tampon géométrique entouré d'une bordure qui s'étend sur le pourtour du tampon. La partie centrale du pansement est moins large que les parties adjacentes, et une languette de préhension dépasse du pourtour de la bordure. Le pansement peut être utilisé pour prévenir les ulcères de pression, ceux situés au niveau du talon par exemple.
Patent CA-3028563-A1 (CA)
Inventor: WATANABE MANABU
IPC: G01N21/88
Filed: 2018-12-27
Abstract: Selon un mode de réalisation, un dispositif d'inspection comprend un corps mobile qui comporte un corps principal mobile qui se déplace en contact avec une première structure; des bras fixés sur le corps principal mobile; un dispositif d'entraînement de bras destiné à entraîner les bras; et un détecteur fixé sur le corps principal mobile ou les bras afin d'inspecter la deuxième structure. Les bras peuvent chacun de manière sélective prendre une position pressée et une position séparée. Lorsque le corps mobile est déplacé, au moins un des bras est dans la position pressée et pressé vers la deuxième structure, et le corps mobile est supporté par les première et deuxième structures.
Patent CA-3030697-A1 (CA)
Inventor: BASTIAN JOLIE ANNE
IPC: C07D403/12
Filed: 2017-07-10
Abstract: The present invention provides compounds of the formula below (I'): where R, and R1-R3 are as described herein, methods of treating patients for certain types of autoimmune diseases and cancer, and processes for preparing the compounds.
Patent CA-3031315-A1 (CA)
Title: Copolymere utilisable comme additif detergent pour carburant
Inventor: PREVOST JULIE
IPC: C08F220/60
Filed: 2017-07-20
Abstract: Copolymère obtenu par copolymérisation d'au moins : - un monomère apolaire (ma) répondant à la formule suivante (I), avec u = 0 ou 1, w = 0 ou 1, E = -O- ou -NH(Z)-, ou -O-CO-, ou -NH-CO- ou -CO-NH-, avec Z représente H ou un groupement alkyle, G représente un groupement choisi parmi un alkyle, un noyau aromatique, un aralkyle, et - un monomère polaire (mb) choisi parmi ceux de formule (II) suivante, dans laquelle t = 0 ou 1 Q est choisi parmi l'atome d'oxygène et le groupement -NR'- avec R' étant choisi parmi un atome d'hydrogène et les chaînes hydrocarbonées, R est une chaîne hydrocarbonée substituée par au moins un groupement ammonium quaternaire et éventuellement un ou plusieurs groupements hydroxyle. Utilisation d'un tel copolymère comme additif détergent dans un carburant liquide de moteur à combustion interne.
Patent CA-3031447-A1 (CA)
Inventor: KESSLER JACK
IPC: A61K47/36
Filed: 2017-07-19
Abstract: L'invention concerne de manière générale une composition topique émolliente de matière qui contient de l'iode moléculaire avec une pression de vapeur efficace réduite. Dans des modes de réalisation spécifiques, la composition réduit la perte d'iode moléculaire dans l'atmosphère dans des conditions de stockage après application sur un tissu mammalien.
Patent CA-3032009-A1 (CA)
Inventor: TREBBI CLAUDIO
IPC: B08B5/02
Filed: 2017-07-24
Abstract: This invention relates to a machine for filling bottles, cartridges, syringes and the like, generally defined as containers, the machine comprising a chamber with an inlet and outlet for containers and at least one intermediate operating station in which the containers are subjected to specific processing, wherein it comprises at least one handling device (2) with several degrees of freedom, automatically controlled and reprogrammable and at least one conduit (4) for washing and sanitising fluids, entirely located outside of said handling device (2) and a dispensing nozzle (5) attached directly to a free end of the conduit (4), said dispensing nozzle (5) being configured to be joined to an adjustable end (6) of the at least one handling device (2) for washing and sanitising said chamber and the containers contained therein.
Patent CA-3035353-A1 (CA)
Title: Compositions d'aerosol
Inventor: STURGIS DAVID ARTHUR
IPC: A61K8/44
Filed: 2017-08-31
Abstract: L'invention concerne une composition d'aérosol personnel comprenant un solvant, un complexe de parfum de cyclodextrine, et un agent propulseur. Le complexe de parfum de cyclodextrine comprend 10 % ou plus de matières premières de parfum, en poids du parfum, ayant : une constante de stabilité de complexe de cyclodextrine d'environ 3,0 ou moins, un ClogP d'environ 2,5 ou moins; et un poids moléculaire moyen en poids d'environ 200 Daltons ou moins.
Patent CA-3037092-A1 (CA)
Title: Compositions pharmaceutiques stables comprenant du glycopyrrolate et du 1,1-difluoroethane (hfa 152a) pour utilisation dans des aerosols-doseurs
Inventor: CORR STUART
IPC: A61P11/00
Filed: 2017-09-18
Abstract: La présente invention concerne une composition pharmaceutique. La composition comprend : (i) un composant médicamenteux comprenant au moins un sel pharmaceutiquement acceptable de giycopyrrolate; et (ii) un composant propulseur comprenant du 1,1-difluoroéthane (HFA -152a).
Patent CA-3039184-A1 (CA)
Title: Oral care compositions and methods of use
Inventor: NESTA JASON
IPC: A61K8/362
Filed: 2016-12-06
Abstract: Disclosed herein are non-aqueous dentifrice compositions comprising (i) a whitening complex comprising crosslinked polyvinylpyrrolidone complexed with hydrogen peroxide; (ii) an off-gas reducing agent selected from sodium sulfate, magnesium sulfate, citric acid and clay; and (iii) an orally acceptable carrier. Methods of making and using the compositions are also provided.
Patent CA-3039298-A1 (CA)
Title: Synchonous monitoring device and method for radial and axial vibration of shearer drum
Inventor: XU SHAOYI
IPC: G01H9/00
Filed: 2018-06-25
Abstract: The present invention discloses a synchronous monitoring device and method for radial and axial vibration of a shearer drum. The monitoring device comprises a laser, a first optical fiber coupler, an optical isolator, a second optical fiber coupler, a third optical fiber coupler, an optical fiber collimator, a first photodetector. a second photodetector, a first signal processing module, and a second signal processing module which are disposed on a shearer ranging arm, as well as a reflective coating disposed on a shearer drum. By measuring a phase difference between original light and reflected light, axial vibration of the shearer drum is monitored, and by measuring an intensity difference between original light and reflected light, radial vibration of the shearer drum is monitored.
Patent CA-3041443-A1 (CA)
Inventor: SHIMONI ALLON
IPC: D06P1/52
Filed: 2017-10-30
Abstract: Provided herein is an inkjet dye-sublimation ink composition that is formulated to interact with an immobilizing composition such that the ink composition coagulates on the surface of an absorptive substrate, thereby substantially limiting soaking of the ink composition into the substrate. Also provided are a printing process and a printing machine, wherein the ink composition is directly printed on the substrate concomitantly with the immobilizing composition, and thereafter undergo heat-pressing to afford a dye-sublimation transfer of the dye to the substrate, thereby forming an image which is characterized by sharp and well defined edges of the dyed areas.
Patent CA-3042666-A1 (CA)
Inventor: LIN YEUN-JUNN
IPC: B63H5/16
Filed: 2019-05-08
Abstract: A propelling system of a powered ship includes a support, outboard motor, guide component and water inlet unit. The support is disposed at a stern. The outboard motor is mounted on the support. A blade wheel is disposed at the bottom of the outboard motor. The axis of the blade wheel is higher than a hull. The guide component has a guide ring for concealing the blade wheel and a nozzle connected to the guide ring. The water inlet unit is disposed at the stern and below the support. The water inlet unit has a water inlet hole and water outlet hole. A water inlet channel is formed between the water inlet hole and water outlet hole. The support enables the outboard motor to be mounted higher. The guide component and water inlet channel enable water to be conveyed at low pressure and ejected at high flow rate.
Patent CA-3042856-A1 (CA)
Title: Vascular grafts, method of manufacturing thereof and articles comprising the same
Inventor: MAGIN CHELSEA MARIE
IPC: D01F6/70
Filed: 2017-11-07
Abstract: Disclosed herein is a method of manufacturing a vascular graft comprising disposing cells of a first cell type on a core having a textured surface, wherein the textured surface comprises a plurality of spaced features, the spaced features being arranged in a plurality of groupings, the groupings of spaced features being arranged with respect to one another so as to define a tortuous path when viewed in a first direction; growing the cells to form a primary cell-seeded construct, wherein the primary cell-seeded construct has a textured inner surface that is a negative image of the textured surface of the core; contacting the primary cell-seeded construct with a second cell type to form a secondary cell-seeded construct; and removing the core to produce the vascular graft.
Patent CA-3049621-A1 (CA)
Title: Process for preparing d-glucaro-6,3-lactone
Inventor: ROY ABHIJEET
IPC: C07D307/33
Filed: 2018-02-07
Abstract: The presently claimed invention is directed to a process for preparing D-glucaro-6,3-lactone from a salt of D-glucaric acid.
Patent CA-3049701-A1 (CA)
Inventor: QU JINYU
IPC: F16H61/28
Filed: 2017-12-28
Abstract: Disclosed is an automotive sixth-gear automatic transmission with a brushless X-by-wire centrifugal ball arm jointing device. A brushless X-by-wire centrifugal ball arm jointing device (10) is arranged between an input gear and driving gear of each gear. By means of controlling the engagement or disengagement of the brushless X-by-wire centrifugal ball arm jointing device (10), the gear shift control to the automotive sixth-gear automatic transmission of the brushless X-by-wire centrifugal ball arm jointing device (10) can be realized. The present invention has the advantages of a compact structure, being capable of dynamically gear shifting, having no mechanical or hydraulic gear-shifting components, and low operation energy consumption, etc.
Patent CA-3050721-A1 (CA)
Title: Systems, devices and methods for analyte sensor insertion
Inventor: RAO VIVEK S
IPC: A61B5/00
Filed: 2018-01-22
Abstract: Systems, devices and methods are provided for inserting at least a portion of an in vivo analyte sensor, such as a dermal sensor, for sensing an analyte level in a bodily fluid of a subject. An applicator is positioned against a skin surface and a force is applied to the applicator causing at least a portion of a sharp and an in vivo analyte sensor to be positioned in the body of the subject. In particular, disclosed herein are embodiments of applicators designed to prevent premature sharp withdrawal and/or reduce the likelihood of improper sensor insertion. Also disclosed are embodiments of applicators including sharp modules having an angled sharp which can be configured to create an insertion path for a sensor.
Patent CA-3051797-A1 (CA)
Title: Binding agents
Inventor: FINLAY WILLIAM JAMES JONATHAN
IPC: C07K16/28
Filed: 2018-01-26
Abstract: The invention relates to antibody molecules and antigen-binding portions thereof which bind specifically to glucocorticoid-induced TNF receptor (GITR). In particular aspects of the invention, the antibody molecules specifically bind to human GITR and cynomolgus monkey GITR. The anti-GITR antibody molecules of the invention have been developed and optimized using CDR sequences derived from a murine anti-GITR antibody 6C8. Medical uses of the antibody molecules are disclosed.
Patent CA-3052018-A1 (CA)
Inventor: FISCHVOGT GREDORY
IPC: A61B17/94
Filed: 2012-10-16
Abstract: An optical trocar system, comprising: an elongated obturator member having at its distal end an optical member, wherein a central section of an outer surface of the optical member includes a pair of diametrically opposed generally convex surfaces, and wherein the central section of the outer surface of the optical member further includes a pair of diametrically opposed generally concave surfaces that are positioned circumferentially between the pair of diametrically opposed generally convex surfaces.
Patent CA-3052491-A1 (CA)
Inventor: FILSTEIN ALEXANDER ELI
IPC: E21B43/12
Filed: 2019-08-19
Abstract: In a process for recovering hydrocarbons from a subterranean reservoir of bituminous sands, steam and solvent are co-injected into the reservoir at an injection pressure at respective injection rates. The injection rates are selected to inject the solvent at a selected solvent weight percentage based on the total weight of injected steam and solvent at a selected injection pressure. The steam injection rate is reduced, and a change in the injection pressure is monitored over a period of time after reducing the steam injection rate. In response to a decrease of the injection pressure over the period of time, increasing the solvent injection rate or the steam injection rate to increase the injection pressure back to the selected value.  The solvent injection rate is increased if a threshold condition has not been met.  Or, the steam injection rate is increased if the threshold condition has been met.
Patent CA-3053944-A1 (CA)
Inventor: MUNIER MELODIE
IPC: G01T1/20
Filed: 2018-02-15
Abstract: The present invention concerns a method for measuring and representing the level of local irradiation doses, in at least two dimensions, comprising: a step of positioning N probes Si sensitive to irradiating radiation, each corresponding to a local zone Zi according to a known topology, a step of acquiring, by each of said probes, the level of radiation ISi detected and periodically recording numerical values ISi(t) a step of converting said numerical values ISi(t) into values DSi(t) corresponding to the radiation dose applied to each of the Z zones associated with a probe Si, according to a calibration table further comprising, during the measurement sequence, the steps of spatial interpolation calculation of at least one estimated irradiation level value ISiv(t) of at least one virtual zone Ziv that is not associated with a probe. The invention also relates to a measurement device for implementing this method.
Patent CA-3054155-A1 (CA)
Title: Piege a tiques et procede de piegeage de tiques
Inventor: JALOWIEC THOMAS WALTER
IPC: A01M1/10
Filed: 2018-01-16
Abstract: L'invention concerne un piège à tiques comportant une colle conçue pour piéger les tiques touchant la colle en collant aux tiques, et un parfum à base de plante qui attire les tiques vers la colle, et un procédé de piégeage de tiques à l'aide du piège à tiques. Le piège à tiques peut être utilisé pour piéger des tiques à l'intérieur d'une habitation ou dans l'environnement.
Patent CA-3054549-A1 (CA)
Title: Particules de distribution contenant un agent benefique
Inventor: LEBRON ARIIEL
IPC: C11D3/50
Filed: 2017-03-16
Abstract: La présente invention concerne des particules de distribution contenant un agent bénéfique, qui peuvent être fournies sous forme de suspensions, des compositions comprenant lesdites particules, et des procédés destinés à fabriquer et à utiliser les particules et compositions mentionnées ci-dessus. Ces suspensions sont stables et, quand elles sont utilisées dans des compositions, par exemple, des compositions de nettoyage ou d'entretien des textiles, les particules se trouvant dans ces suspensions augmentent d'efficacité de la distribution de l'agent bénéfique, permettant ainsi d'utiliser des quantités plus faibles d'agents bénéfiques. Outre le fait de réduire la quantité de l'agent bénéfique, ces particules permettent l'utilisation d'une large gamme d'agents bénéfiques.
Patent CA-3055311-A1 (CA)
Inventor: TIMMINS GRAHAM
IPC: C07C215/68
Filed: 2018-02-02
Abstract: La présente invention concerne de l'ambroxol à isotope 13C et/ou 2H amélioré ("ambroxol à isotope amélioré") et son utilisation dans le traitement d'infections par autophagie, en particulier des infections mycobactériennes ainsi que d'autres infections, des états pathologiques et/ou des affections du poumon, tels que la tuberculose, comprenant notamment, la tuberculose pharmacorésistante et la tuberculose multirésistante aux médicaments. L'invention concerne également des compositions pharmaceutiques comprenant de l'ambroxol à isotope amélioré, seul ou en combinaison avec un agent bioactif supplémentaire, en particulier des antibiotiques du groupe rifamycine, comprenant un modulateur d'autophagie supplémentaire (un agent actif pour favoriser ou inhiber l'autophagie), et donc utiles contre un état pathologique et/ou une affection induit(e) par l'autophagie, particulièrement un état pathologique et/ou une affection induit(e) par l'autophagie qui se produit dans les poumons, par exemple, une infection par Mycobacterium, la bronchopneumopathie chronique obstructive (BPCO), l'asthme, la fibrose pulmonaire, la fibrose kystique, la maladie de Sjögren et le cancer du poumon (cancer du poumon à petites cellules et cancer du poumon non à petites cellules), entre autres états pathologiques et/ou affections, en particulier du poumon. Selon un autre mode de réalisation, la présente invention concerne des procédés de traitement d'états pathologiques et/ou affections par autophagie, comprenant notamment des états pathologiques ou des affections par autophagie qui se produisent principalement dans les poumons d'un patient. Selon un mode de réalisation supplémentaire, la présente invention concerne des procédés de synthèse de composés.
Patent CA-3058541-A1 (CA)
Title: Amhrii-binding compounds for preventing or treating lung cancers
Inventor: BARRET JEAN-MARC
IPC: A61K31/337
Filed: 2018-04-13
Abstract: The present invention relates to a human AMHRII-binding agent for its use for preventing or treating a lung cancer, and especially a non-small call lung cancer (NSCLC), and even more especially a NSCLC selected in a group comprising epidermoid NSCLC, adenocarcinoma NSCLC, large cells NSCLC and squamous cell carcinoma NSCLC and neuroendocrine NSCLC.
Patent CA-3059255-A1 (CA)
Inventor: MARKOWTIZ SANFORD
IPC: A61K31/437
Filed: 2018-04-09
Abstract: L'invention concerne une méthode de traitement de prévention, de réduction au minimum et/ou d'inversion de l'insuffisance cardiaque congestive, de la cardiomyopathie et/ou de la réduction de la fraction d'éjection cardiaque chez un sujet en ayant besoin, comprenant l'administration au sujet d'une quantité thérapeutiquement efficace d'un inhibiteur 15-PGDH.
Patent CA-3059345-A1 (CA)
Title: Process for isolating nucleated cells and nucleated cell populations and uses thereof
Inventor: SITAR GIAMMARIA
IPC: C12N5/078
Filed: 2017-04-06
Abstract: The present disclosure provides processes for isolating target nucleated cells, such as fetal mesenchymal stem cells, from non-nucleated red blood cells, populations of cells obtainable by the processes of the disclosure, and methods of using isolated targeted nucleated cells methods and their progeny for detecting fetal abnormalities and stem cell therapy.
Patent CA-3063369-A1 (CA)
Inventor: IMOTO TAKAYUKI
IPC: A61K47/18
Filed: 2018-05-14
Abstract: Le problème que cherche à résoudre la présente invention est de fournir un matériau de base en forme de bâtonnet qui possède une résistance à la rupture souhaitée pour un matériau de base en forme de bâtonnet même si la quantité de composé peptido-lipidique est réduite. L'invention concerne un matériau de base en forme de bâtonnet comprenant : un composé peptido-lipidique comprenant au moins un type de composé sélectionné parmi les composés décrits par la formule (1), un composé similaire, ou un sel pharmaceutiquement utile de celui-ci; un tensioactif; de l'eau; du 1,2-alcanediol ou du 1,3-alcanediol; au moins un type d'acide gras; et un dérivé de l'acide alginique. (Dans la formule, R1 représente un groupe aliphatique en C9C23, R2 représente un atome d'hydrocarbure ou un groupe alkyle en C1C4 pouvant comporter une chaîne ramifiée en C1C2, R3 représente un groupe (CH2)nX, n représentant une valeur comprise entre 1 et 4 et X représentant un hétérocycle fusionné comprenant un cycle à 5 chaînons, un cycle à 6 chaînons ou un cycle à 5 chaînons et un cycle à 6 chaînons, et pouvant porter entre 1 et 3 groupes amino, groupes guanidino, groupes CONH2, ou atomes d'azote.)